Bing Chen
Impact in
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
- Inflammatory Biomarkers in Disease Prognosis
-
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
- Immune cells in cancer
Papers in
- Oncology 32
- CAR-T cell therapy research 7
- Cancer Immunotherapy and Biomarkers 6
- Inflammatory Biomarkers in Disease Prognosis 4
- Cancer Cells and Metastasis 4
- Colorectal Cancer Screening and Detection 3
- Co-authors
- Peipei Xu (8 shared papers)Jian Ouyang (3 shared papers)Ruju Wang (2 shared papers)Yong Hu (2 shared papers)Huaqin Zuo (1 shared paper)Arsalan Ahmed (1 shared paper)Alan J. Korman (2 shared papers)Mark Selby (2 shared papers)
- Journals
- Scientific Reports (2 papers)International Journal of Radiation Oncology*Biology*Physics (2 papers)Journal of Clinical Oncology (2 papers)PLoS ONE (2 papers)Molecular Therapy — Oncolytics (1 paper)
- Partner nations
- ChinaUnited StatesTaiwan
In The Last Decade
Bing Chen
39 papers receiving 759 citations
Peers
Comparison fields: 5 of 103
- Oncology 424
- Immunology 196
- Hematology 60
- Cancer Research 76
- Biomaterials 63
Countries citing papers authored by Bing Chen
This map shows the geographic impact of Bing Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bing Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bing Chen more than expected).
Fields of papers citing papers by Bing Chen
This network shows the impact of papers produced by Bing Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bing Chen. The network helps show where Bing Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside Bing Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 44 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 175 | |
| 2 | 2017 | 143 | |
| 3 | 2016 | 78 | |
| 4 | 2007 | 40 | |
| 5 | 2015 | 31 | |
| 6 | 2020 | 30 | |
| 7 | 2021 | 24 | |
| 8 | 2018 | 23 | |
| 9 | 2023 | 22 | |
| 10 | 2016 | 21 | |
| 11 | 1999 | 21 | |
| 12 | 2019 | 21 | |
| 13 | 2023 | 20 | |
| 14 | 2022 | 17 | |
| 15 | 2020 | 13 | |
| 16 | 2024 | 11 | |
| 17 | 2021 | 8 | |
| 18 | 2024 | 8 | |
| 19 | 2013 | 8 | |
| 20 | 2019 | 8 |
About Bing Chen
Bing Chen is a scholar working on Oncology, Molecular Biology, Pulmonary and Respiratory Medicine, Immunology and Epidemiology, having authored 44 papers that have together received 773 indexed citations. Recurring topics across this work include CAR-T cell therapy research (7 papers), Cancer Immunotherapy and Biomarkers (6 papers), Inflammatory Biomarkers in Disease Prognosis (4 papers), Cancer Cells and Metastasis (4 papers), Cancer Genomics and Diagnostics (3 papers), Multiple Myeloma Research and Treatments (3 papers), Colorectal Cancer Screening and Detection (3 papers) and Genetic factors in colorectal cancer (2 papers). The work is most often cited by research in Oncology (424 citations), Immunology (196 citations), Hematology (60 citations), Cancer Research (76 citations) and Biomaterials (63 citations). Bing Chen has collaborated with scholars based in China, United States and Taiwan. Frequent co-authors include Peipei Xu, Jian Ouyang, Ruju Wang, Yong Hu, Huaqin Zuo, Arsalan Ahmed, Alan J. Korman, Mark Selby, Pina M. Cardarelli and Changyu Wang. Their work appears in journals such as Scientific Reports, International Journal of Radiation Oncology*Biology*Physics, Journal of Clinical Oncology, PLoS ONE and Molecular Therapy — Oncolytics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.